Crowdonomics
All companies
PIROUETTE MEDICAL (YC S21) logo

PIROUETTE MEDICAL (YC S21)

Operating

Pirouette Medical Inc.

Healthcare · Technology · Founded 2017

Life-saving injections as easy as pushing a button

Valuation cap ⓘ
$55.0M
As of Jan 2025 · from Reg CF Offering (2024) · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$18,673,684
Crowd $4.7M · Private $14.0M · 7 rounds since 2021

Financials

FY2021–FY2025 · from SEC filings · hover any figure for its source
$0
−$768K
2021
$0
−$2.9M
2022
$0
−$3.6M
2023
$0
−$4.1M
2024
$0
−$5.4M
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2021 reviewed
FY2022 reviewed
FY2023 audited
FY2024 audited
FY2025 audited
Income statement
Revenue
$0
$0
$0
$0
$0
Cost of goods sold
$0
$0
$0
$0
$0
Net income
-$767,977
-$2,934,376
-$3,597,016
-$4,050,003
-$5,360,471
Taxes paid
$0
$0
$0
$0
$0
Balance sheet
Cash
$5,550,952
$6,212,307
$2,094,498
$1,610,924
$2,076,640
Accounts receivable
$0
$0
$0
$0
$0
Total assets
$6,584,382
$7,057,533
$4,504,151
$3,878,452
$4,374,437
Short-term debt
$6,667
$132,693
$190,461
$497,330
$501,599
Long-term debt
$0
$3,281,501
$4,271,434
$7,388,869
$13,241,055
Total liabilities
$6,667
$3,414,194
$4,461,895
$7,886,199
$13,742,654
Other
Headcount
—
13
—
9
17

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Valuation caps on SAFE / convertible note rounds
$55.0M
Valuation cap
Reg CF · SAFE · Feb 2024

Dashed amber bars are a SAFE or convertible note's valuation cap — the most it converts at, not what the company is worth.

Cap table

Share counts as of Dec 31, 2025
Preferred Stock · 6.19%Common Stock · 48.0%Series A5 Preferred Stock · 24.5%Series A3 Preferred Stock · 7.62%Series A1 Preferred Stock · 6.19%Series A4 Preferred Stock · 5.25%Series A2 Preferred Stock · 2.25%
ClassOutstandingVotes / shareShare of totalLiquidationLast price
Preferred Stockpreferred(as of Dec 31, 2024)1,288,64016.19%1× non-participating · paid 1st—
Common Stock10,000,000148.0%paid 2nd—
Series A5 Preferred Stockpreferred5,100,888—24.5%——
Series A3 Preferred Stockpreferred1,587,054—7.62%——
Series A1 Preferred Stockpreferred1,288,640—6.19%——
Series A4 Preferred Stockpreferred1,093,863—5.25%——
Series A2 Preferred Stockpreferred468,793—2.25%——
Total20,827,878100%

Shares outstanding over timein today's share terms

11M5.4M0
Dec 2024Dec 2025
Common StockPreferred StockSeries A1 Preferred StockSeries A2 Preferred StockSeries A3 Preferred StockSeries A4 Preferred StockSeries A5 Preferred StockRound opened

Principal holders% as the filing states it, Apr 20, 2026

  • Conor Cullinane22.7%of votes
  • Everyone else (not named in filings)77.3%

Sold to the crowd

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Raised $1.1MInvestors 1
Reg CF · SAFE · Feb 2026Closedvia WeFunder
Raised $0 / $2.4M
Raised $2.4MInvestors 1
Reg CF · SAFE · Feb 2024Closedvia WeFunder
Raised $4.7M / $5MValuation cap $55M
Raised $2.6MInvestors 2
Raised $7MInvestors 29
Raised $1MInvestors 8

Team

5 people
Matthew KaneFounder
Principal Technical Advisor, Co-founder, Board Member
Conor R. Cullinane, Ph.D.
President & CEO
Elijah Kapas
Chief Technology Officer
Joseph M Nemmers
Board Member
Parinaz Motamedy
Board Member

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFewer than 300 holders of record

Filed 2 of 3 annual reports (FY2023–FY2025)

29 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

  • Form C-ARApr 20, 20260001870611-26-000005
    EDGAR
  • Form DMar 18, 20260001870611-26-000004
    EDGAR
  • Form CFeb 9, 20260001870611-26-000002
    EDGAR
  • Form C-ARApr 17, 20250001870611-25-000004
    EDGAR
  • Form DApr 1, 20250001870611-25-000003
    EDGAR
  • Form C/AFeb 21, 20250001670254-25-000105
    EDGAR
  • Form C/AJan 24, 20250001670254-25-000029
    EDGAR
  • Form C/AJan 16, 20250001670254-25-000015
    EDGAR
Source: ManualCIK 0001870611

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.